TY - ABST

T1 - Extraction of mRNA from coagulated horse blood and analysis of inflammation-related cytokine responses to coagulation

A1 - Bovbjerg,Kirsten Katrine Lindegaard

A1 - Heegaard,Peter M. H.

A1 - Skovgaard,Kerstin

AU - Bovbjerg,Kirsten Katrine Lindegaard

AU - Heegaard,Peter M. H.

AU - Skovgaard,Kerstin

PY - 2010

Y1 - 2010

N2 - Coagulated blood is a rich source of mRNA that allows the study of the regulation of expression of cytokine and other genes. However, while several methods are available for isolation of RNA from whole blood and tissues, protocols for purification of mRNA from clotted blood are not generally available. Here, a protocol for RNA extraction from highly clotted blood was optimized and the regulation of a number of cytokine genes compared to stabilized blood was studied. Whole blood samples from 10 clinically healthy horses were incubated for 24 hours at 37°C and RNA was extracted from the peripheral blood mononuclear cells present in the blood clot, homogenizing the clot by rotating knife homogenization (GentleMACS, Miltenyi Biotec) in the presence of QIAzol extraction buffer (Qiagen). The RNA extracted yielded high concentrations of total RNA (50-265 ng/μl) and quality measures (RIN=8.5-9.2), comparable with that purified by standard methods from stabilized blood. Cytokine mRNA expression was assessed by reverse transcribed quantitative real time PCR and it was found that 24-hour clotting led to a significant increase in the concentrations of mRNA of the pro-inflammatory cytokines interleukin-1β (IL-1β), interleukin-1-receptor antagonist (IL-1ra), interleukin-15 (IL-15), and interleukin-8 (IL-8). These findings that a coagulation-induced inflammation-related cytokine response takes place in whole blood upon clotting. The extraction method provides reproducible and reliable results allowing the recovery of quantifiable high-quality RNA for molecular expression analysis.

AB - Coagulated blood is a rich source of mRNA that allows the study of the regulation of expression of cytokine and other genes. However, while several methods are available for isolation of RNA from whole blood and tissues, protocols for purification of mRNA from clotted blood are not generally available. Here, a protocol for RNA extraction from highly clotted blood was optimized and the regulation of a number of cytokine genes compared to stabilized blood was studied. Whole blood samples from 10 clinically healthy horses were incubated for 24 hours at 37°C and RNA was extracted from the peripheral blood mononuclear cells present in the blood clot, homogenizing the clot by rotating knife homogenization (GentleMACS, Miltenyi Biotec) in the presence of QIAzol extraction buffer (Qiagen). The RNA extracted yielded high concentrations of total RNA (50-265 ng/μl) and quality measures (RIN=8.5-9.2), comparable with that purified by standard methods from stabilized blood. Cytokine mRNA expression was assessed by reverse transcribed quantitative real time PCR and it was found that 24-hour clotting led to a significant increase in the concentrations of mRNA of the pro-inflammatory cytokines interleukin-1β (IL-1β), interleukin-1-receptor antagonist (IL-1ra), interleukin-15 (IL-15), and interleukin-8 (IL-8). These findings that a coagulation-induced inflammation-related cytokine response takes place in whole blood upon clotting. The extraction method provides reproducible and reliable results allowing the recovery of quantifiable high-quality RNA for molecular expression analysis.

UR - http://leukocytebiology.org/default.aspx

BT - 2010 Annual Meeting SLB & IEIIS

T2 - 2010 Annual Meeting SLB & IEIIS

ER -